A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...
Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer ...
A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...
Researchers examined CA-125 levels at diagnosis, defining them as elevated/borderline or negative/normal in 250,749 patients ...
The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for American Indian, Asian, or Black patients versus White patients. HealthDay News — Black and American ...
REDWOOD CITY, CA, USA I March 31, 2025 I Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development ...
Ovarian cancer is the fifth leading cause of cancer-related deaths among women in the U.S. However, the racial bias makes it ...
The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for patients of American Indian, Asian, or Black race versus White patients. HealthDay News — Black and American ...
MONDAY, March 24, 2025 (HealthDay News) -- Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer diagnosis, according to a study ...